101 related articles for article (PubMed ID: 18304233)
1. High incidence of aneuploidy in low grade urothelial carcinomas.
Alvarez AL
Int J Urol; 2008 Mar; 15(3):279. PubMed ID: 18304233
[No Abstract] [Full Text] [Related]
2. DNA-aneuploidy as marker for neoplasia in G1-urothelial carcinomas.
Planz B; Striepecke E; Wolff JM; Effert P; Jakse G; Böcking A
Gen Diagn Pathol; 1996 Oct; 142(2):69-73. PubMed ID: 8950570
[TBL] [Abstract][Full Text] [Related]
3. Chromosomal instability in bladder cancer.
Florl AR; Schulz WA
Arch Toxicol; 2008 Mar; 82(3):173-82. PubMed ID: 18253719
[TBL] [Abstract][Full Text] [Related]
4. Coexistent intraurothelial carcinoma and muscle-invasive urothelial carcinoma of the bladder: clonality and somatic down-regulation of DNA mismatch repair.
Blanes A; Rubio J; Sanchez-Carrillo JJ; Diaz-Cano SJ
Hum Pathol; 2009 Jul; 40(7):988-97. PubMed ID: 19368958
[TBL] [Abstract][Full Text] [Related]
5. Urothelial tumorigenesis: a tale of divergent pathways.
Wu XR
Nat Rev Cancer; 2005 Sep; 5(9):713-25. PubMed ID: 16110317
[TBL] [Abstract][Full Text] [Related]
6. 9p21 index as estimated by dual-color fluorescence in situ hybridization is useful to predict urothelial carcinoma recurrence in bladder washing cytology.
Kawauchi S; Sakai H; Ikemoto K; Eguchi S; Nakao M; Takihara H; Shimabukuro T; Furuya T; Oga A; Matsuyama H; Takahashi M; Sasaki K
Hum Pathol; 2009 Dec; 40(12):1783-9. PubMed ID: 19733894
[TBL] [Abstract][Full Text] [Related]
7. [Genetic features of urothelial carcinoma of the bladder and the upper urinary tract].
Cussenot O; Davin JL
Prog Urol; 2003 Nov; 13(5 Suppl 2):1233. PubMed ID: 15816391
[No Abstract] [Full Text] [Related]
8. Origin of urothelial carcinoma after renal transplant determined by fluorescence in situ hybridization.
Master VA; Meng MV; Koppie TM; Carroll PR; Grossfeld GD
J Urol; 2002 Jun; 167(6):2521-2. PubMed ID: 11992074
[No Abstract] [Full Text] [Related]
9. [Anti-ErbB targeted therapy and urothelial tumors].
Amsellem-Ouazana D; Goldwasser F; Bieche I; Lidereau R; Zerbib M
Prog Urol; 2005 Dec; 15(6 Suppl 1):1229-35. PubMed ID: 16734210
[No Abstract] [Full Text] [Related]
10. DNA aneuploidy in G1-urothelial carcinomas of the urinary bladder.
Borchers H; Planz B; Jakse G; Böcking A
Urol Int; 1994; 52(3):145-50. PubMed ID: 8203053
[TBL] [Abstract][Full Text] [Related]
11. Association of TSC1/hamartin, 14-3-3sigma, and p27 expression with tumor outcomes in patients with pTa/pT1 urothelial bladder carcinoma.
Mhawech-Fauceglia P; Alvarez V; Fischer G; Beck A; Herrmann FR
Am J Clin Pathol; 2008 Jun; 129(6):918-23. PubMed ID: 18480009
[TBL] [Abstract][Full Text] [Related]
12. Arsenic methylation capability, heme oxygenase-1 and NADPH quinone oxidoreductase-1 genetic polymorphisms and the stage and grade of urothelial carcinomas.
Huang SK; Chiu AW; Pu YS; Huang YK; Chung CJ; Tsai HJ; Yang MH; Chen CJ; Hsueh YM
Urol Int; 2008; 80(4):405-12. PubMed ID: 18587252
[TBL] [Abstract][Full Text] [Related]
13. How to combine the molecular profile with the clinicopathological profile of urothelial neoplastic lesions.
van der Kwast TH
Scand J Urol Nephrol Suppl; 2008 Sep; (218):175-84. PubMed ID: 18815932
[TBL] [Abstract][Full Text] [Related]
14. Activation of RAS family genes in urothelial carcinoma.
Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA
J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097
[TBL] [Abstract][Full Text] [Related]
15. Implications of p53 gene mutations on patient survival in transitional cell carcinoma of the bladder: a long-term study.
Salinas-Sánchez AS; Lorenzo-Romero JG; Giménez-Bachs JM; Sánchez-Sánchez F; Donate-Moreno MJ; Rubio-Del-Campo A; Hernández-Millán IR; Segura-Martín M; Atienzar-Tobarra M; Escribano-Martínez J
Urol Oncol; 2008; 26(6):620-6. PubMed ID: 18367096
[TBL] [Abstract][Full Text] [Related]
16. Does Schistosoma-associated bladder cancer differ from urothelial cancer? Proof from the laboratory and clinic.
Zaghloul MS
Cancer Genet Cytogenet; 2008 Jan; 180(2):160-2. PubMed ID: 18206545
[No Abstract] [Full Text] [Related]
17. Targeting the genetic basis of transitional cell carcinoma.
Gomella LG
J Urol; 2006 Jun; 175(6):1986. PubMed ID: 16697780
[No Abstract] [Full Text] [Related]
18. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
[TBL] [Abstract][Full Text] [Related]
19. Urothelial carcinoma with abundant myxoid stroma.
Tavora F; Epstein JI
Hum Pathol; 2009 Oct; 40(10):1391-8. PubMed ID: 19535127
[TBL] [Abstract][Full Text] [Related]
20. Chromosomal analysis as prognostic tool in transitional cell carcinoma: preliminary report.
Gonick P; Kalathoor R; Fuscaldo K
Urology; 1980 Nov; 16(5):527-9. PubMed ID: 7445296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
